Cryo Cell International (CCEL) EBT (2010 - 2026)

Cryo Cell International has disclosed EBT across 17 years of filings, most recently posting $70309.0 for Q1 2026.

• In Q1 2026, EBT fell 86.83% year-over-year to $70309.0; the TTM figure through Feb 2026 stood at -$2.8 million (down 210.11% YoY), while the FY2025 annual figure was -$2.3 million, down 183.35% from the prior year.
• EBT improved to $70309.0 in Q1 2026, from -$4.6 million in the prior quarter.
• Over the last five years, EBT for CCEL reached as high as $1.5 million in Q2 2024 and fell as low as -$16.0 million in Q4 2023.
• The 5-year median for EBT is $640966.0 (2022), against an average of -$559310.0.
• Annual changes were most pronounced in 2023 — EBT sank 2669.13% — and 2024, when it surged 324.98%.
• A 5-year view of EBT shows it stood at $622508.0 in 2022, then slumped by 2669.13% to -$16.0 million in 2023, then jumped by 94.73% to -$842434.0 in 2024, then tumbled by 449.83% to -$4.6 million in 2025, then jumped by 101.52% to $70309.0 in 2026.
• According to Business Quant data, EBT over the past three periods registered $70309.0, -$4.6 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.